Piekarska Katarzyna, Wołkowicz Tomasz, Zacharczuk Katarzyna, Stepuch Agata, Gierczyński Rafał
Department of Bacteriology and Biocontamination Control, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.
Pathogens. 2023 Jan 27;12(2):193. doi: 10.3390/pathogens12020193.
Salmonellosis remains the second most common zoonosis in Europe. Resistance to fluoroquinolones (FQs) in has been increasing worldwide, with WHO considering FQ-resistant spp. as high-priority pathogens. The aim of this study was a retrospective analysis of the molecular mechanisms of FQ resistance, detected among clinical ciprofloxacin-resistant belonging to the most common serotypes. The whole genome sequences (WGS) of tested isolates were also analysed for the occurrence of other antimicrobial resistance determinants. Out of a total of 1051 collected in the years 2018-2019, 447 strains belonging to the most common serotypes in Poland were selected were screened for FQ resistance using the pefloxacin disc test according to EUCAST recommendations. All pefloxacin-resistant isolates were confirmed as ciprofloxacin-resistant using the E-test. A total of 168 (37.6%) , which belonged to seven serotypes, were resistant to ciprofloxacin (mostly Hadar, Virchow and Newport). A hundred randomly selected were investigated by WGS. A total of 127 QRDR mutations in GyrA and ParC were identified in 93 isolates. The genes were the only PMQR determinants detected and were found in 19% of the sequenced isolates. Moreover, 19 additional resistance genes (including: R, A) were identified among the FQ-resistant tested that confer resistance to clinically important antibiotics such as β-lactams, tetracyclines, sulphonamides, aminoglycosides and phenicol, respectively). In conclusion, FQ resistance of human in Poland is rising towards a critical level and needs to be tightly monitored.
沙门氏菌病仍是欧洲第二常见的人畜共患病。全球范围内,沙门氏菌对氟喹诺酮类药物(FQs)的耐药性一直在增加,世界卫生组织将耐氟喹诺酮类的沙门氏菌属视为高优先级病原体。本研究的目的是对临床分离的耐环丙沙星、属于最常见血清型的沙门氏菌中检测到的氟喹诺酮耐药分子机制进行回顾性分析。还对测试菌株的全基因组序列(WGS)进行分析,以检测其他抗菌药物耐药决定因素的存在情况。在2018 - 2019年收集的总共1051株沙门氏菌中,选择了447株属于波兰最常见血清型的菌株,根据欧洲抗菌药物敏感性试验委员会(EUCAST)的建议,使用培氟沙星纸片扩散法筛选氟喹诺酮耐药性。使用E-test法确认所有耐培氟沙星的分离株均对环丙沙星耐药。共有168株(37.6%)属于7种血清型的沙门氏菌对环丙沙星耐药(主要是哈达尔、维尔肖和纽波特血清型)。随机选择100株沙门氏菌进行全基因组测序。在93株分离株中,共鉴定出127个gyrA和parC基因的喹诺酮耐药决定区(QRDR)突变。qnr基因是检测到的唯一质粒介导的喹诺酮耐药决定因素,在19%的测序分离株中发现。此外,在测试的耐氟喹诺酮沙门氏菌中还鉴定出另外19个耐药基因(包括:R、A),它们分别赋予对β-内酰胺类、四环素类、磺胺类、氨基糖苷类和氯霉素等临床重要抗生素的耐药性。总之,波兰人源沙门氏菌的氟喹诺酮耐药性正上升至临界水平,需要密切监测。